Skip to content

New Shingles Vaccine Shingrix Found 97% Effective Against Condition

January 12, 2020

From the Medical Daily website

Higher-than-expected demand for the new and “remarkable” shingles vaccine Shingrix from GlaxoSmithKline has been so pervasive throughout the United States, the vaccine is now in short supply but only temporarily.

GlaxoSmithKline said it will significantly increase the number of available doses for the rest of the year and into 2020. The high demand for Shingrix is due to its efficacy.

Continue reading

From → Health & Safety

Comments are closed.